APA

Bharadwaj S. S., Poojary B., Nandish S. K. M., Kengaiah J., Kirana M. P., Shankar M. K., Das A. J., Kulal A. & Sannaningaiah D. (2018). Efficient Synthesis and in Silico Studies of the Benzimidazole Hybrid Scaffold with the Quinolinyloxadiazole Skeleton with Potential α-Glucosidase Inhibitory, Anticoagulant, and Antiplatelet Activities for Type-II Diabetes Mellitus Management and Treating Thrombotic Disorders. : ACS omega.

Chicago

Bharadwaj S Shashidhar, Poojary Boja, Nandish Sharath Kumar M, Kengaiah Jayanna, Kirana Mugaranja P, Shankar Madan Kumar, Das Anupam J, Kulal Ananda and Sannaningaiah Devaraja. 2018. Efficient Synthesis and in Silico Studies of the Benzimidazole Hybrid Scaffold with the Quinolinyloxadiazole Skeleton with Potential α-Glucosidase Inhibitory, Anticoagulant, and Antiplatelet Activities for Type-II Diabetes Mellitus Management and Treating Thrombotic Disorders. : ACS omega.

Harvard

Bharadwaj S. S., Poojary B., Nandish S. K. M., Kengaiah J., Kirana M. P., Shankar M. K., Das A. J., Kulal A. and Sannaningaiah D. (2018). Efficient Synthesis and in Silico Studies of the Benzimidazole Hybrid Scaffold with the Quinolinyloxadiazole Skeleton with Potential α-Glucosidase Inhibitory, Anticoagulant, and Antiplatelet Activities for Type-II Diabetes Mellitus Management and Treating Thrombotic Disorders. : ACS omega.

MLA

Bharadwaj S Shashidhar, Poojary Boja, Nandish Sharath Kumar M, Kengaiah Jayanna, Kirana Mugaranja P, Shankar Madan Kumar, Das Anupam J, Kulal Ananda and Sannaningaiah Devaraja. Efficient Synthesis and in Silico Studies of the Benzimidazole Hybrid Scaffold with the Quinolinyloxadiazole Skeleton with Potential α-Glucosidase Inhibitory, Anticoagulant, and Antiplatelet Activities for Type-II Diabetes Mellitus Management and Treating Thrombotic Disorders. : ACS omega. 2018.